MedPath

REGENERON IRELAND DESIGNATED ACTIVITY COMPANY

🇮🇪Ireland
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

5

EMA:4
CIMA_AEMPS:1

Drug Approvals

Lynozyfic

Authorization Status
Authorised
Approval Date
Apr 23, 2025
EMA

Lynozyfic

Authorization Status
Authorised
Approval Date
Apr 23, 2025
EMA

Ordspono

Authorization Status
Authorised
Approval Date
Aug 22, 2024
EMA

Libtayo

Authorization Status
Authorised
Approval Date
Jun 28, 2019
EMA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.